Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions. (2022)
Attributed to:
Engineering growth factor microenvironments - a new therapeutic paradigm for regenerative medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcell.2022.988699
PubMed Identifier: 36425532
Publication URI: http://europepmc.org/abstract/MED/36425532
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in cell and developmental biology
ISSN: 2296-634X